Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human CD18 Recombinant Antibody

Anti-Human CD18 Recombinant Antibody

Product Number

YR1184

Alias

科研级 Erlizumab ( 厄利珠单抗 ), Anti-CD18 Recombinant Antibody, Research Grade Erlizumab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Erlizumab ( 厄利珠单抗 ), Anti-CD18 Recombinant Antibody, Research Grade Erlizumab
Catalog NumberYR1184
Molecular NameErlizumab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1
FormulationPBS, pH7.5
BackgroundErlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock.
CAS Number211323-03-4
ApplicationELISA, FCM, IP, FuncS, IF, Neut, ICC
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD18[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now